David P Pleynet
About David P Pleynet
David P. Pleynet serves as the Executive Director and Head of Global IP at Deciphera Pharmaceuticals, where he has worked since 2019. He possesses extensive experience in intellectual property law and science, with a background that includes roles at ImmunoGen, Ropes & Gray LLP, and Amylin Pharmaceuticals.
Current Role at Deciphera Pharmaceuticals
David P Pleynet serves as the Executive Director, Head of Global IP, and Associate General Counsel at Deciphera Pharmaceuticals. He has held this position since 2019, contributing to the company's intellectual property strategy and legal matters. His role involves overseeing global intellectual property initiatives and ensuring compliance with relevant regulations. Deciphera Pharmaceuticals is located in Waltham, Massachusetts, United States.
Previous Experience in the Pharmaceutical Industry
Prior to his current role, David Pleynet worked at ImmunoGen, Inc. as Director of Chemistry IP & Patent Counsel from 2016 to 2019. He also held positions at TorreyPines Therapeutics as Senior Scientist/Principal Research Scientist from 2002 to 2008, and at Amylin Pharmaceuticals as a Scientist from 1997 to 1998. His experience spans various roles that combine scientific research with intellectual property management.
Education and Legal Credentials
David Pleynet has an extensive educational background. He earned a Bachelor of Science in Chemistry from Coventry University from 1988 to 1990. He completed his PhD in Organic Chemistry and Natural Product Synthesis at the University of Leeds from 1990 to 1994. He also obtained a Juris Doctor (J.D.) degree, graduating Cum Laude from Suffolk University Law School from 2013 to 2017. He is registered to practice before the United States Patent and Trademark Office (USPTO).
Research and Patent Contributions
David Pleynet has co-invented 17 issued US patents and applications, along with numerous corresponding foreign patents. His research experience covers therapeutic areas such as diabetes, obesity, cancer, inflammation, auto-immune disorders, and Alzheimer’s disease. He has also authored 12 publications in peer-reviewed journals, showcasing his contributions to scientific literature.
International Collaboration and Language Skills
Fluent in French, David Pleynet enhances communication in international collaborations. His language skills facilitate effective interactions with global partners and stakeholders, contributing to the success of cross-border projects in the pharmaceutical and legal sectors.